Mammomat B.brilliant (mammogram system)

2024: Product Announcement

On September 30, 2024, Siemens Healthineers announced the release of the mammography system in the next generation 3D Mammomat B.brilliant. Thanks to the use of this complex, there is no need for breast biopsy.

The device uses the technology of breast tomosynthesis with an angle of 50 degrees, which provides high resolution in depth. During tomosynthesis, the device takes several pictures, after which a special algorithm processes this data and forms a 3D image. Tomosynthesis makes it possible to recognize the slightest disorders of the structure of the breast. Thus, the likelihood of detecting the disease in the initial stages, when it is well amenable to therapy, increases.

𝓲

Siemens Healthineers

Mammomat B.brilliant's 3D mammography platform solves the problem of tissue overlap, which manifests itself in two-dimensional imaging, regardless of breast density. The system separates overlapping layers of tissue, helping to visualize lesions that would otherwise be hidden. The platform accelerates the interpretation of tomograms and facilitates the analysis of microcalcinates. In addition, PlatinumTomo technology is implemented, which reduces the blur inherent in 3D imaging and helps radiologists make more accurate diagnoses. However, the new UltraHD image reconstruction feature reduces artifacts.

Compression plates, thanks to the soft edges and shape optimized for the breast, simplify positioning and help increase the comfort level of patients. The laser guide element provides accurate positioning of the breast. Mammomat's 3D mammography-enabled B.brilliant system has received approval from the U.S. Food and Drug Administration (FDA).^[1]

Notes